65.73
price up icon9.31%   5.60
after-market Handel nachbörslich: 65.73
loading
Schlusskurs vom Vortag:
$60.13
Offen:
$61.11
24-Stunden-Volumen:
61,087
Relative Volume:
0.59
Marktkapitalisierung:
$611.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-
EPS:
-
Netto-Cashflow:
$-82.84M
1W Leistung:
+3.95%
1M Leistung:
+95.68%
6M Leistung:
+12.86%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$60.08
$66.01
1-Wochen-Bereich:
Value
$55.10
$66.01
52-Wochen-Spanne:
Value
$30.00
$98.00

Korro Bio Inc Stock (KRRO) Company Profile

Name
Firmenname
Korro Bio Inc
Name
Telefon
617-468-1999
Name
Adresse
ONE KENDALL SQUARE. BUILDING 600-700, CAMBRIDGE
Name
Mitarbeiter
101
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
KRRO's Discussions on Twitter

Korro Bio Inc Stock (KRRO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-03-28 Bestätigt H.C. Wainwright Buy
2024-02-27 Eingeleitet BMO Capital Markets Outperform
2023-12-04 Eingeleitet H.C. Wainwright Buy
2023-11-29 Eingeleitet RBC Capital Mkts Outperform
2023-11-10 Eingeleitet Piper Sandler Overweight
2023-02-15 Herabstufung Chardan Capital Markets Buy → Neutral
2023-02-13 Herabstufung Cowen Outperform → Market Perform
2021-09-22 Herabstufung Goldman Buy → Neutral
2021-01-27 Hochstufung JP Morgan Neutral → Overweight
2020-12-22 Eingeleitet B. Riley Securities Buy
2020-07-14 Eingeleitet Oppenheimer Outperform
2020-05-18 Herabstufung JP Morgan Overweight → Neutral
2019-10-28 Eingeleitet Cowen Outperform
2019-10-28 Eingeleitet Goldman Buy
2019-10-28 Eingeleitet JP Morgan Overweight
Alle ansehen

Korro Bio Inc Aktie (KRRO) Neueste Nachrichten

pulisher
Nov 04, 2024

Korro Bio (NASDAQ:KRRO) Shares Gap DownShould You Sell? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - The Manila Times

Nov 04, 2024
pulisher
Nov 04, 2024

Korro Bio, Inc. Announces Submission to Bellberry HREC for Phase 1/2 Clinical Study of KRRO-110 for AATD - Marketscreener.com

Nov 04, 2024
pulisher
Oct 28, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 5.1%Time to Sell? - MarketBeat

Oct 28, 2024
pulisher
Oct 25, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for clinical leap By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Korro Bio (NASDAQ:KRRO) Coverage Initiated at Raymond James - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook - Investing.com Australia

Oct 22, 2024
pulisher
Oct 22, 2024

Raymond James Initiates Coverage of Korro Bio (KRRO) with Strong Buy Recommendation - MSN

Oct 22, 2024
pulisher
Oct 21, 2024

Korro Bio price target raised to $105 from $95 at RBC Capital - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

RBC lifts Korro Bio stock target on positive RNA editing outlook By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 21, 2024

Royal Bank of Canada Boosts Korro Bio (NASDAQ:KRRO) Price Target to $105.00 - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Korro Bio initiated with a Strong Buy at Raymond James - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 21, 2024
pulisher
Oct 19, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Insider Selling: Korro Bio, Inc. (NASDAQ:KRRO) CFO Sells 10,216 Shares of Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Korro bio CFO Vineet Agarwal sells $799,526 in stock By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio shares target lifted, buy rating on RNA editing potential - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio (NASDAQ:KRRO) Trading Down 4.1%Should You Sell? - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

HC Wainwright Increases Korro Bio (NASDAQ:KRRO) Price Target to $115.00 - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Korro Bio price target raised to $115 from $100 at H.C. Wainwright - TipRanks

Oct 18, 2024
pulisher
Oct 17, 2024

BMO maintains steady target on Korro Bio shares By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 16, 2024

500: Something went wrong - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

180 Life Sciences, Korro Bio, NuScale Power: Retail Investors Turn Most Bullish On These Stocks - Barchart

Oct 16, 2024
pulisher
Oct 16, 2024

BMO maintains steady target on Korro Bio shares - Investing.com India

Oct 16, 2024
pulisher
Oct 16, 2024

What is KRRO’s price-to-sales ratio telling us about the company’s value? - US Post News

Oct 16, 2024
pulisher
Oct 16, 2024

Korro Bio (NASDAQ:KRRO) Shares Gap UpTime to Buy? - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Wall Street Analysts Think Korro Bio, Inc. (KRRO) Could Surge 239.54%: Read This Before Placing a Bet - Yahoo Finance UK

Oct 16, 2024
pulisher
Oct 16, 2024

RNA-Editing Stocks Soar on Wave Life’s Breakthrough Trial Data - Bloomberg

Oct 16, 2024
pulisher
Oct 15, 2024

Millennium Management LLC Purchases 23,307 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Korro Bio, Inc. (NASDAQ:KRRO) Short Interest Down 11.9% in September - MarketBeat

Oct 15, 2024
pulisher
Sep 30, 2024

Korro Bio's SWOT analysis: RNA editing pioneer's stock poised for growth - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society - The Manila Times

Sep 30, 2024
pulisher
Sep 30, 2024

Point72 Asset Management L.P. Raises Stock Position in Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Sep 30, 2024
pulisher
Sep 25, 2024

NEA Management Company LLC Boosts Stock Position in Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

19,148 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Bought by Bank of New York Mellon Corp - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

19,148 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Purchased by Bank of New York Mellon Corp - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Tri Locum Partners LP Takes Position in Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Sep 23, 2024
pulisher
Sep 20, 2024

Brown Brothers Harriman & Co. Acquires Shares of 813 Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Stock Surge: Corcept Therapeutics Inc (CORT) Closes at 40.92, Marking a -3.19 Increase/Decrease - The Dwinnex

Sep 20, 2024
pulisher
Sep 20, 2024

Korro Bio, Inc. Forecasted to Post Q3 2024 Earnings of ($2.79) Per Share (NASDAQ:KRRO) - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Korro Bio (NASDAQ:KRRO) Given "Outperform" Rating at Royal Bank of Canada - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Korro Bio (NASDAQ:KRRO) Given “Outperform” Rating at Royal Bank of Canada - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Novo Nordisk and Korro Bio Take RNA Editing to Cardiometabolic Diseases - Inside Precision Medicine

Sep 20, 2024
pulisher
Sep 19, 2024

Korvest Ltd Director Buys First Shares - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

Korro Bio - The Pharma Letter

Sep 19, 2024
pulisher
Sep 19, 2024

ORGN stock touches 52-week high at $1.73 amid market optimism - Investing.com Australia

Sep 19, 2024
pulisher
Sep 19, 2024

Research Analysts Offer Predictions for Oruka Therapeutics, Inc.’s Q3 2024 Earnings (NASDAQ:ORKA) - Defense World

Sep 19, 2024

Finanzdaten der Korro Bio Inc-Aktie (KRRO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Korro Bio Inc-Aktie (KRRO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Agarwal Vineet
Chief Financial Officer
Oct 17 '24
Sale
78.26
10,216
799,527
0
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):